HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intravitreal triamcinolone acetonide as an adjuvant in the management of acute retinal necrosis.

AbstractOBJECTIVE:
To determine the role of intravitreal triamcinolone acetonide (IVTA) as an adjuvant in the management of acute retinal necrosis (ARN).
DESIGN:
Interventional case series.
PARTICIPANTS:
Four eyes of 4 patients diagnosed with ARN were studied.
METHODS:
This pilot case series included 4 patients who presented with clinical features suggestive of ARN. IVTA was injected 1 to 2 weeks after initiation of antiviral therapy and concurrent usage of oral corticosteroids. The disease course and clinical outcome were observed. The patients received additional treatment depending on the sequelae of ARN.
RESULTS:
Signs of reduction in vitritis and resolution of retinitis were observed as early as 1 week after IVTA was administered. In all 4 patients, inflammation promptly resolved with no untoward effects like raised intraocular pressure or worsening of the retinitis. A final visual acuity of 20/40 or better was achieved in 3 of 4 patients after appropriate treatment of ARN-related complications.
CONCLUSIONS:
Intravitreal triamcinolone under antiviral cover could be a useful adjunct to systemic steroids in the treatment of ARN.
AuthorsHimadri Choudhury, Animesh Jindal, Kopal Mithal, Abhishek C Bawdekar, Avinash Pathengay
JournalCanadian journal of ophthalmology. Journal canadien d'ophtalmologie (Can J Ophthalmol) Vol. 49 Issue 3 Pg. 279-82 (Jun 2014) ISSN: 1715-3360 [Electronic] England
PMID24862775 (Publication Type: Journal Article)
CopyrightCopyright © 2014 Canadian Ophthalmological Society. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Antiviral Agents
  • Glucocorticoids
  • Triamcinolone Acetonide
  • Valine
  • Valacyclovir
  • Acyclovir
Topics
  • Acyclovir (analogs & derivatives, therapeutic use)
  • Adolescent
  • Antiviral Agents (therapeutic use)
  • Chemotherapy, Adjuvant
  • Eye Diseases (physiopathology)
  • Female
  • Glucocorticoids (adverse effects, therapeutic use)
  • Humans
  • Intravitreal Injections
  • Male
  • Middle Aged
  • Pilot Projects
  • Retinal Necrosis Syndrome, Acute (drug therapy, physiopathology)
  • Retinitis (physiopathology)
  • Triamcinolone Acetonide (adverse effects, therapeutic use)
  • Valacyclovir
  • Valine (analogs & derivatives, therapeutic use)
  • Visual Acuity (physiology)
  • Vitreous Body (physiopathology)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: